Joshua Hadfield was a normal, healthy developing child as a toddler. In the midst of the 2010 H1N1 swine flu frenzy and fear mongering about the horrible consequences children face if left unvaccinated, the Hadfield’s had Joshua vaccinated with Glaxo’s Pandermrix influenza vaccine. Within weeks, Joshua could barely wake up, sleeping up to nineteen hours a day. Laughter would trigger seizures.
Joshua was diagnosed with narcolepsy, “an incurable, debilitating condition” associated with acute brain damage. Today we can look back at Pandermrix as a horrible vaccine. Research indicates that it was associated with a 1400% increase in narcolepsy risk. More recently, a team of Finnish scientists at Finland’s National Institute for Health and Welfare, recorded 800 cases of narcolepsy associated with this vaccine. Vaccine ingredients other than the engineered viral antigen are most often believed to be the primary culprits to adverse vaccine reactions. The Finnish research, on the other hand, indicated that the vaccine’s altered viral nucleotide likely contributed to the sudden rise in sleeping sickness.
Although Pandermrix was pulled from the market, it should never have been approved and released in the first place. This is a classic case of regulatory negligence by health officials and the WHO which promulgates flu vaccines around the world. Like all vaccines, which are now commonly fast tracked through government health regulatory bodies for rapid release upon the public, it should have been tested more thoroughly and more rigorously reviewed. (Click to Article)